Aripiprazole vs Durvalumab

## Aripiprazole vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Aripiprazole** and **Durvalumab**.

## Mechanism of Action

**Aripiprazole**: Partial agonist at D2 and 5-HT1A receptors.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Aripiprazole — 75 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Aripiprazole — C23H27Cl2N3O2; Durvalumab — N/A.

**Molecular Weight**: Aripiprazole — 448.3850 g/mol; Durvalumab — N/A.

**Type**: Aripiprazole — Small molecule; Durvalumab — Antibody.